Yes the FDA will approve you very soon.
- Forums
- ASX - By Stock
- Why Cynata's GvHD Treatment Might Not Need a Phase Two Trial for FDA Approval
CYP
cynata therapeutics limited
Add to My Watchlist
6.25%
!
17.0¢

Yes the FDA will approve you very soon.
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.5¢ | 16.0¢ | $45.60K | 278.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 695374 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 107670 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 695374 | 0.160 |
4 | 66451 | 0.155 |
2 | 55000 | 0.150 |
2 | 45937 | 0.140 |
1 | 25000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 5131 | 1 |
0.175 | 85472 | 3 |
0.180 | 118716 | 7 |
0.185 | 58190 | 2 |
0.190 | 9090 | 2 |
Last trade - 15.17pm 18/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online